Arlocabtagene autoleucel:一种用于重度预治疗复发/难治性多发性骨髓瘤的靶向 GPRC5D CAR-T 细胞疗法 Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma. PubMed 2026/09/03 发表BloodQ1 · IF 23.9(JCR 2025) 人群:成人靶点:CD38靶点:BCMA靶点:GPRC5D技术:CAR-T多发性骨髓瘤